Palo Alto Investors’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,471,592
Closed -$13.9M 54
2025
Q4
$13.9M Sell
4,471,592
-992,757
-18% -$2.83M 1.93% 14
2025
Q3
$14.4M Sell
5,464,349
-274,664
-5% -$605K 2.66% 14
2025
Q2
$7.06M Sell
5,739,013
-537,880
-9% -$587K 1.5% 16
2025
Q1
$6.9M Sell
6,276,893
-200
-0% -$231 1.31% 18
2024
Q4
$5.68M Hold
6,277,093
0.88% 18
2024
Q3
$6.19M Hold
6,277,093
0.8% 22
2024
Q2
$5.66M Sell
6,277,093
-114,682
-2% -$85.8K 0.66% 23
2024
Q1
$7.54M Buy
6,391,775
+432,887
+7% +$476K 0.85% 25
2023
Q4
$6.53M Sell
5,958,888
-571,400
-9% -$422K 0.59% 23
2023
Q3
$5.44M Buy
6,530,288
+3,065,136
+88% +$3.53M 0.51% 20
2023
Q2
$4.16M Hold
3,465,152
0.34% 20
2023
Q1
$4.37M Buy
3,465,152
+3,427,402
+9,079% +$6.56M 0.36% 18
2022
Q4
$81.9K Sell
37,750
-1,712,901
-98% -$14.1M 0.01% 29
2022
Q3
$21M Hold
1,750,651
1.66% 14
2022
Q2
$14.7M Sell
1,750,651
-6,106
-0.3% -$47.3K 1.28% 16
2022
Q1
$15.2M Sell
1,756,757
-16,193
-0.9% -$156K 1.18% 17
2021
Q4
$20.1M Hold
1,772,950
1.28% 17
2021
Q3
$22.3M Hold
1,772,950
1.35% 18
2021
Q2
$14.4M Hold
1,772,950
0.79% 20
2021
Q1
$16.4M Buy
1,772,950
+33,900
+2% +$342K 0.93% 20
2020
Q4
$16.8M Buy
1,739,050
+661,850
+61% +$6.52M 0.88% 19
2020
Q3
$13.4M Buy
1,077,200
+872,986
+427% +$11.6M 0.73% 20
2020
Q2
$2.65M Buy
+204,214
New +$2.57M 0.16% 27

Other funds holding GOSS

Palo Alto Investors's GOSS Position: Q1 2026 in Review

Palo Alto Investors sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 4,471,592 shares — an estimated $13.9M sold.

Palo Alto Investors first reported a position in GOSS in Q2 2020 and held it in 23 quarters. The position peaked at $22.3M in Q3 2021. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Palo Alto Investors reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • Palo Alto Investors sold 4,471,592 Gossamer Bio shares in Q1 2026, an estimated $13.9M.
  • Palo Alto Investors first reported a position in Gossamer Bio in Q2 2020 and held it in 23 quarters.
  • Palo Alto Investors's Gossamer Bio position peaked at $22.3M in Q3 2021.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Palo Alto Investors's 13F filing for Q1 2026, filed 15 May 2026.